Skip to main content
Supplement ScienceSupplementScience

Benefits of Vitex (Chasteberry)

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • PMS symptom relief — Schellenberg (2001) demonstrated in a landmark RCT of 170 women that 20mg of Vitex extract (Ze 440) reduced PMS symptoms by 52% vs 24% for placebo over 3 cycles, with significant improvements in irritability, mood, breast tenderness, and headache
  • Menstrual cycle regulation — vitex normalizes the luteal phase by suppressing excess prolactin via dopamine D2 receptor agonism, which promotes adequate progesterone production in the second half of the cycle
  • Hyperprolactinemia — in women with mildly elevated prolactin, vitex has been shown to reduce prolactin levels and restore normal menstrual cycling; this effect is dose-dependent and well-documented
  • Luteal phase support — by normalizing the progesterone-to-estrogen ratio, vitex may improve fertility outcomes in women with luteal phase defects, though evidence is still moderate

What the Research Says

Vitex (Chasteberry), derived from *Vitex agnus-castus*, is supported by robust clinical evidence for its role in women's health, particularly in managing premenstrual syndrome (PMS). A pivotal randomized controlled trial (RCT) by Schellenberg (2001) demonstrated significant symptom reduction in 170 women using the Ze 440 extract, with a 52% improvement rate compared to 24% for placebo. This study highlighted the efficacy of vitex in alleviating PMS symptoms.

A systematic review and meta-analysis by Verkaik et al. (2017) further corroborated these findings, analyzing 14 RCTs and concluding a large pooled effect of vitex on reducing PMS symptoms compared to placebo. The review emphasized its effectiveness, particularly for psychological complaints, while noting limitations such as high risk of bias and heterogeneity.

The pharmacological mechanism of vitex is well-documented: diterpenes in the extract act as dopamine D2 receptor agonists in the anterior pituitary, reducing prolactin secretion. This regulation supports normal corpus luteum function and progesterone production, addressing symptoms associated with hyperprolactinemia (Wuttke et al., 2003). A double-blind placebo-controlled study by Wuttke et al. (2003) involving 60 women confirmed that chaste tree extract reduces serum prolactin levels and improves premenstrual mastodynia.

Overall, Vitex agnus-castus demonstrates a favorable safety profile and consistent efficacy in managing PMS symptoms, supported by multiple studies across different methodologies.

Related Conditions

PmsHormonal Imbalance
Full Vitex (Chasteberry) Guide

References

  1. RCTSchellenberg R (2001). Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. DOI PubMed
  2. Meta-analysisVerkaik S, Moll AC, Steegers-Theunissen RP, et al. (2017). The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. DOI PubMed
  3. RCTWuttke W, Jarry H, Christoffel V, Spengler B, Seidlová-Wuttke D (2003). Chaste tree (Vitex agnus-castus) — pharmacology and clinical indications. Phytomedicine. DOI PubMed